A NEGATIVE MODULATOR OF HEDGEHOG SIGNALLING FOR USE IN TREATING TH2 -MEDIATED DISEASES

The invention provides means for treating Th1- and Th2-mediated diseases, such as asthma, allergic dermatitis and Th2-driven cancer. The invention extends to pharmaceutical compositions for use in treating such conditions, and to methods of treatment. The invention also extends to adjuvants and vacc...

Full description

Saved in:
Bibliographic Details
Main Authors FURMANSKI, ANNA L, SALDANA, JOSE IGNACIO, CROMPTON, TESSA
Format Patent
LanguageEnglish
French
German
Published 21.01.2015
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides means for treating Th1- and Th2-mediated diseases, such as asthma, allergic dermatitis and Th2-driven cancer. The invention extends to pharmaceutical compositions for use in treating such conditions, and to methods of treatment. The invention also extends to adjuvants and vaccines per se, and to their use in enhancing the immunomodulatory activity of immunogens.
Bibliography:Application Number: EP20130711112